Variable (statistic analysis) | Factor | Df | F-value/χ2 | p-value |
---|---|---|---|---|
Mosquito development experiment with living yeasts (axenic, conventional, and gnotobiotic larvae) | ||||
Developmental time until adult emergence (chi-square) | Infection status | 11 | 1334.699 | < 2.2e- 16 |
Sex | 1 | 285.918 | < 2.2e- 16 | |
Infection status × sex | 11 | 26.374 | 5.71e- 03 | |
Survival (chi-square) | Infection status | 11 | 72.967 | 3.32e- 11 |
Sex ratio (chi-square) | Infection status | 11 | 12.568 | 0.320 |
Adult size (ANOVA 2) | Infection status | 11 | 7.022 | 7.73e- 11 |
Sex | 1 | 2047.364 | < 2.2e- 16 | |
Infection status × sex | 11 | 1.728 | 0.070 | |
Residuals | 374 | |||
Female size (ANOVA 2) | Infection status | 11 | 3.152 | 6.01e- 04 |
Residuals | 196 | |||
Male size (ANOVA 2) | Infection status | 11 | 6.851 | 1.41e- 09 |
Residuals | 178 | |||
Mosquito development experiment with “heat-killed” yeasts (axenic, conventional, and gnotobiotic larvae) | ||||
Developmental time until adult emergence (chi-square) | Infection status | 11 | 873.052 | < 2.2e- 16 |
Sex | 1 | 184.209 | < 2.2e- 16 | |
Infection status*Sex | 11 | 9.277 | 0.590 | |
Survival (chi-square) | Infection status | 11 | 56.252 | 4.57e- 08 |
Sex ratio (chi-square) | Infection status | 11 | 16.703 | 0.117 |
Oviposition bioassays | ||||
Total number of eggs laid by each female (chi-square) | Yeast species | 5 | 27.128 | 5.38e- 05 |
Oviposition preference (chi-square) | Yeast species | 5 | 22.076 | 5.06e- 04 |
Yeast concentration | 2 | 11.774 | 0.002 | |
Yeast conc. × yeast species | 10 | 13.847 | 0.180 | |
Oviposition stimulation (chi-square) | Yeast species | 5 | 14.508 | 0.012 |
Yeast concentration | 2 | 28.684 | 5.90e- 07 | |
Yeast conc. × yeast species | 10 | 14.889 | 0.136 | |
Measurements of metabolism parameters in second/fourth instars (axenic, conventional, and gnotobiotic larvae) | ||||
Riboflavin concentration (ANOVA) | Larval instar | 1, 88 | 536.946 | < 2.2e- 16 |
Infection status | 3, 88 | 79.321 | < 2.2e- 16 | |
Larval instar × infection status | 3, 88 | 20.810 | 2.80e- 10 | |
Uricase activity (chi-square) | Larval instar | 1 | 642.720 | < 2.2e- 16 |
Infection status | 3 | 34.430 | 1.60e- 07 | |
Larval instar × infection status | 3 | 27.230 | 5.27e- 06 | |
Uric acid concentration (ANOVA) | Larval instar | 1, 72 | 291.815 | < 2.2e- 16 |
Infection status | 3, 72 | 16.634 | 2.61e- 08 | |
Larval instar × infection status | 3, 72 | 1.460 | 0.232 | |
Protein concentration (chi-square) | Larval instar | 1 | 643.66 | < 2.2e- 16 |
Infection status | 3 | 33.30 | 2.78e- 07 | |
Larval instar × infection status | 3 | 2.04 | 0.564 |